Phosphorus oxychloride → 4-Chloro-7-methoxy-6-(3-(methylsulfonyl)propoxy)quinazoline
반응식
O[C:2]1[C:11]2[C:6](=[CH:7][C:8]([O:20][CH3:21])=[C:9]([O:12][CH2:13][CH2:14][CH2:15][S:16]([CH3:19])(=[O:18])=[O:17])[CH:10]=2)[N:5]=[CH:4][N:3]=1.O=P(Cl)(Cl)[Cl:24]>>[Cl:24][C:2]1[C:11]2[C:6](=[CH:7][C:8]([O:20][CH3:21])=[C:9]([O:12][CH2:13][CH2:14][CH2:15][S:16]([CH3:19])(=[O:18])=[O:17])[CH:10]=2)[N:5]=[CH:4][N:3]=1참가 물질
3
실험 절차
The intermediate 4-hydroxy-7-methoxy-6-(3-(methylsulfonyl)propoxy)quinazoline (700 mg, 2.24 mmol) from the previous step was reacted with POCl3 in the manner described in Example 4A Step 2 to give 4-chloro-7-methoxy-6-(3-(methylsulfonyl)propoxy)quinazoline (480 mg, 1.45 mmol, 65%). LC-MS (ESI) m/z 331 (M+H)+.
출처 및 근거
- ORD 기록
- ord-980e0e8a277f4f83adfa18dfc76a155b
- 출처 데이터셋
- uspto-grants-2016_04
- 특허 번호
- US09320739B2
반응 노트
불러오는 중…